We are live on ! Find out more
NCM

Nantahala Capital Management Portfolio holdings

AUM $2.72B
1-Year Est. Return 121.58%
This Fund
S&P 500
This Quarter Est. Return
+13.03%
1 Year Est. Return
+121.58%
3 Year Est. Return
+308.64%
5 Year Est. Return
+308.9%
10 Year Est. Return
+2,888.73%
AUM
$1.67B
AUM Growth
+$502M
Cap. Flow
+$375M
Cap. Flow %
22.44%
Top 10 Hldgs %
57.54%
Holding
148
New
14
Increased
40
Reduced
54
Closed
20

Top Buys

Rank Stock Value
1
SLNO
Soleno Therapeutics
SLNO
+$70.1M
2
EOLS icon
Evolus
EOLS
+$22.3M
3
RDNW
RideNow Group
RDNW
+$18M
4
ESTA icon
Establishment Labs
ESTA
+$17.1M
5
IWM icon
iShares Russell 2000 ETF
IWM
+$13.6M

Top Sells

Rank Stock Value
1
CASH icon
Pathward Financial
CASH
+$8.58M
2
RH icon
RH
RH
+$5.38M
3
VTYX
Ventyx Biosciences
VTYX
+$5.13M
4
IMTX icon
Immatics
IMTX
+$4.66M
5
MLKN icon
MillerKnoll
MLKN
+$4.42M

Sector Composition

Rank Sector Weight
1 Healthcare 35.39%
2 Consumer Discretionary 8.45%
3 Financials 4.4%
4 Communication Services 3.48%
5 Technology 2.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PTON icon
51
CALL
Peloton Interactive
PTON
$2.42B
$7.19M 0.43%
1,180,000
+328,000
+38% +$1.77M
DHX icon
52
DHI Group
DHX
$158M
$6.84M 0.41%
2,639,687
-58,514
-2% -$151K
DXPE icon
53
DXP Enterprises
DXPE
$2.99B
$6.8M 0.41%
201,829
+21,842
+12% +$713K
RDI icon
54
Reading International Class A
RDI
$35.2M
$6.5M 0.39%
3,402,203
+526,163
+18% +$1.01M
ENVA icon
55
CALL
Enova International
ENVA
$6.29B
$6.03M 0.36%
+109,000
New +$5.03M
NSPR icon
56
InspireMD
NSPR
$37.5M
$5.81M 0.35%
2,066,456
+298,406
+17% +$859K
NNBR icon
57
NN Inc
NNBR
$300M
$5.63M 0.34%
1,407,222
+54,079
+4% +$129K
ANTX icon
58
AN2 Therapeutics
ANTX
$213M
$5.09M 0.3%
248,278
-108,511
-30% -$1.82M
IDYA icon
59
IDEAYA Biosciences
IDYA
$3.54B
$4.96M 0.3%
139,298
-6,562
-4% -$196K
AGS
60
DELISTED
PlayAGS
AGS
$4.78M 0.29%
566,588
-27,986
-5% -$207K
AYX
61
DELISTED
Alteryx Inc
AYX
$4.67M 0.28%
+99,093
New +$3.85M
SVRA icon
62
Savara
SVRA
$1.17B
$4.64M 0.28%
987,903
-51,461
-5% -$197K
XTNT icon
63
Xtant Medical Holdings
XTNT
$62.6M
$4.52M 0.27%
4,000,000
– –
MLKN icon
64
MillerKnoll
MLKN
$1.64B
$4.46M 0.27%
167,148
-173,080
-51% -$4.42M
THTX
65
DELISTED
Theratechnologies
THTX
$4.35M 0.26%
+2,682,228
New +$4.04M
SNDX icon
66
CALL
Syndax Pharmaceuticals
SNDX
$1.82B
$4.32M 0.26%
200,000
– –
VNDA icon
67
Vanda Pharmaceuticals
VNDA
$304M
$4.28M 0.26%
1,013,251
+13,251
+1% +$53.5K
OPTN
68
DELISTED
OptiNose
OPTN
$4.06M 0.24%
209,795
-10,734
-5% -$196K
DRIO icon
69
DarioHealth
DRIO
$74.7M
$4.02M 0.24%
116,838
-3,872
-3% -$138K
ENVA icon
70
Enova International
ENVA
$6.29B
$3.98M 0.24%
71,865
+18,615
+35% +$860K
ASPS icon
71
Altisource Portfolio Solutions
ASPS
$63.3M
$3.79M 0.23%
133,014
+19,956
+18% +$633K
COGT icon
72
Cogent Biosciences
COGT
$7.1B
$3.77M 0.23%
640,936
+65,936
+11% +$505K
IMAX icon
73
CALL
IMAX
IMAX
$2.81B
$3.75M 0.22%
250,000
– –
ALTG icon
74
Alta Equipment Group
ALTG
$237M
$3.74M 0.22%
302,509
-20,123
-6% -$217K
CLRB icon
75
Cellectar Biosciences
CLRB
$20.8M
$3.74M 0.22%
+45,019
New +$3.35M
1 2
3
4 5

Similar funds

TAM
Timucuan Asset Management Jacksonville, Florida $2.72B AUM 4.95% 1-Year Est. Return
XL
XN LP New York $2.72B AUM 46.67% 1-Year Est. Return
NB
Nicolet Bankshares Green Bay, Wisconsin $2.71B AUM 17.55% 1-Year Est. Return
PA
Profund Advisors Bethesda, Maryland $2.72B AUM 47.27% 1-Year Est. Return
BCM
Bowie Capital Management Richardson, Texas $2.71B AUM 5.42% 1-Year Est. Return
SCM
Shaolin Capital Management Miami, Florida $2.71B AUM 64.57% 1-Year Est. Return
HCM
Hollencrest Capital Management Newport Beach, California $2.7B AUM 23.62% 1-Year Est. Return
GC
Giverny Capital Montreal, Quebec, Canada $2.73B AUM 14.09% 1-Year Est. Return

Nantahala Capital Management's Q4 2023 Portfolio in Review

As of Q4 2023, Nantahala Capital Management held 148 positions worth $1.67B, up 43% from $1.17B the previous quarter. Its ten largest holdings account for 58% of the portfolio.

Nantahala Capital Management deployed $375M of net new capital in Q4 2023, opening 14 new positions and adding to 40 existing holdings. Its largest new stake was Abivax: 1,010,034 shares worth $10.8M.

By sector, the portfolio is most concentrated in Healthcare at 35% of assets, down from 36% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was Pathward Financial, an estimated $8.58M trimmed.

  • Nantahala Capital Management's largest Q4 2023 buy was Abivax: 1,010,034 shares worth $10.8M.
  • Nantahala Capital Management added most to Soleno Therapeutics in Q4 2023, an estimated $70.1M increase.
  • Nantahala Capital Management's biggest Q4 2023 reduction was Pathward Financial, cutting an estimated $8.58M.
  • Nantahala Capital Management fully exited RH in Q4 2023, selling an estimated $5.38M.
  • Nantahala Capital Management's ten largest holdings make up 58% of its $1.67B portfolio in Q4 2023.
  • Nantahala Capital Management opened 14 new positions and closed 20 in Q4 2023.
  • Nantahala Capital Management's portfolio value rose 43% quarter-over-quarter to $1.67B.

Based on Nantahala Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.